1. Articles from ecancer

    ecancer.org

  2. 1-24 of 34 1 2 »
    1. Cell surface protein may offer big target in treating high-risk childhood cancers

      Cell surface protein may offer big target in treating high-risk childhood cancers

      Oncology researchers studying high-risk children's cancers have identified a protein that offers a likely target for immunotherapy--harnessing the immune system in medical treatments.

      In cell cultures and animal models, a potent drug attached to an...

      Read Full Article
      Mentions: Immunotherapy
    2. New research points to potential targeted treatments of neuroblastoma tumours

      New research points to potential targeted treatments of neuroblastoma tumours

      Genetic variations appear to pre-dispose children to developing certain severe forms of neuroblastoma, according to new research by the University of Chicago Medicine.

      The findings lay the groundwork for developing more targeted treatments for...

      Read Full Article
      Mentions: MYCN
    3. Cancer in children adversely affects parents' income and employment

      "The researchers found that parents’ income from employment decreased significantly following a child’s cancer diagnosis, with an overall 21 percent reduction in mothers’ earnings and a 10 percent reduction in fathers’ earnings for the year of diagnosis when compared with control parents.  The relative reduction in income of mothers was evident up to six years post-diagnosis, whereas fathers’ income was reduced for two years post-diagnosis."

      Read Full Article
    4. Researchers describe a new type of cancer therapy

      Researchers describe a new type of cancer therapy

      "We tested RCn's tumour killing efficacy in cell lines of numerous cancers, including sarcomas, lymphoma and neuroblastoma," said Timothy Cripe, MD, PhD, principal investigator in the Center for Childhood Cancer and Blood Disease in The Research Institute at Nationwide Children's and senior author on the paper. "We observed anticancer activity of the RCn amines in all the cancer cell lines analysed."  Researchers found that RCn, and RC16 in particular, is 10 times more effective in harming tumour cells than regular cells. That means the low dose needed to kill cancer will have minimal effect on normal cells."

      Read Full Article
      Mentions: Chemotherapy
    5. Improving the long-term health of childhood cancer survivors

      Improving the long-term health of childhood cancer survivors

      "SIOPE together with all partners in the PanCareSurFup project strives to find solutions to the challenges they encounter on a daily basis with useful initiatives, such as the “Survivorship Passport” and its related guidelines for follow-up.  The current lack of information on many patients’ medical history becomes particularly critical as children become adults, or as they move to another country.  Moreover, a difficult relationship or a lack of understanding from doctors can characterise the survivor’s journey."

      Read Full Article
      Mentions: Treatment
    6. Gene often lost in childhood cancer crucial in cells' life or death decision

      "Our data strongly suggest that KIF1Bβ, which is localised on chromosome 1p36, might be such a neuroblastoma tumour suppressor gene", says principal investigator Susanne Schlisio at the Department of Microbiology, Tumor and Cell Biology at Karolinska Institutet and Assistant Member at the Ludwig Institute for Cancer Research in Stockholm, Sweden.  Neuroblastoma tumours originate from the same transient progenitor cells -- neural crest cells -- that give rise to the nervous system along with other tissues.  Members of some families are at higher risk than others to develop tumours that originate from these cells due to mutations in specific genes. The research team ...

      Read Full Article
    1-24 of 34 1 2 »
  1. Categories

    1. Research:

      Cancer Cell, Case Report, Cells and Stem Cells, Clinical Research, Conferences, Disease Classification, Drug, Drug Delivery, Drug Resistance, Epigenetics and Epigenomics, General, Genetics, Genomics, Guidelines, Immune Therapy, Induction, Long Term Effects, Low / Intermediate Risk, Nanotechnology, Olfactory Neuroblastoma, Onco-Fertility, Oncogenesis, Other Cancers, Personalized Medicine, Pharma, Pre-Clinical, Prognostics, PubMed, Review, Small Molecules, Surgery, Survivorship, Trials, Tumor Biology, Virotherapy
    2. Business:

      Funding, IP, Pharma
    3. Non-Profit:

      Advocacy, Charity, Events, Foundation, Funding, Human Interest
    4. Press Release:

      Announcement, News, Pharma
    5. General:

      Adolescent and Young Adults, Bioethics, Blog, Burden of Treatment, Children & Families, Diagnosis and Detection, Drug Development, Epidemiology, Imaging, Incidence, Information, News, Overview of the Disease, Pain Control, Palliative Care, Psychosocial, Regulation, Side-Effects, Social, Supportive Care, Treatment
    6. Media:

      Audio, Blogs, Video